Magnetic resonance imaging-based brain tumor grades classification and grading via convolutional neural networks and genetic algorithms

Deep convolutional neural network-based 3D fluorescence sensor array for sugar identification in serum based on the oxidase-mimicking property of CuO nanoparticles

Developing sensor arrays capturing comprehensive fluorescence (FL) spectra from a single probe is crucial for understanding sugar structures with very high similarity in biofluids. Therefore, the analysis of highly similar sugar' structures in biofluids based on the entire FL of a single nanozyme probe needs more concern, which makes the development of novel alternative approaches highly wanted for biomedical and other applications. Herein, a well-designed deep learning model with intrinsic information of 3D FL of CuO nanoparticles (NPs)' oxidase-like activity was developed to classify and predict the concentration of a group of sugars with very similar chemical structures in different media. The findings presented that the overall accuracy of the developed model in classifying the nine selected sugars was (99-100 %), which prompted us to transfer the developed model to predict the concentration of the selected sugars at a concentration range of (1-100 μM). The transferred model also gave excellent results (R2 = 97-100 %). Therefore, the model was extended to other more complex applications, namely the identification of mixtures of sugars in serum and the detection of polysaccharides in different media such as serum and lake water. Notably, LOD for fructose was determined at 4.23 nM, marking a 120-fold decrease compared to previous studies. Our developed model was also compared with other deep learning-based models, and the results have demonstrated remarkable progress. Moreover, the identification of other possible coexisting interference substances in lake water samples was considered. This work marks a significant advancement, opening avenues for the widespread application of sensor arrays integrating nanozymes and deep learning techniques in biomedical and other diverse fields.

Enhanced MRI-based brain tumour classification with a novel Pix2pix generative adversarial network augmentation framework

The scarcity of medical imaging datasets and privacy concerns pose significant challenges in artificial intelligence-based disease prediction. This poses major concerns to patient confidentiality as there are now tools capable of extracting patient information by merely analysing patient's imaging data. To address this, we propose the use of synthetic data generated by generative adversarial networks as a solution. Our study pioneers the utilisation of a novel Pix2Pix generative adversarial network model, specifically the 'image-to-image translation with conditional adversarial networks,' to generate synthetic datasets for brain tumour classification. We focus on classifying four tumour types: glioma, meningioma, pituitary and healthy. We introduce a novel conditional deep convolutional neural network architecture, developed from convolutional neural network architectures, to process the pre-processed generated synthetic datasets and the original datasets obtained from the Kaggle repository. Our evaluation metrics demonstrate the conditional deep convolutional neural network model's high performance with synthetic images, achieving an accuracy of 86%. Comparative analysis with state-of-the-art models such as Residual Network50, Visual Geometry Group 16, Visual Geometry Group 19 and InceptionV3 highlights the superior performance of our conditional deep convolutional neural network model in brain tumour detection, diagnosis and classification. Our findings underscore the efficacy of our novel Pix2Pix generative adversarial network augmentation technique in creating synthetic datasets for accurate brain tumour classification, offering a promising avenue for improved disease prediction and treatment planning.

Medical image foundation models in assisting diagnosis of brain tumors: a pilot study

OBJECTIVES

To build self-supervised foundation models for multicontrast MRI of the whole brain and evaluate their efficacy in assisting diagnosis of brain tumors.

METHODS

In this retrospective study, foundation models were developed using 57,621 enhanced head MRI scans through self-supervised learning with a pretext task of cross-contrast context restoration with two different content dropout schemes. Downstream classifiers were constructed based on the pretrained foundation models and fine-tuned for brain tumor detection, discrimination, and molecular status prediction. Metrics including accuracy, sensitivity, specificity, and area under the ROC curve (AUC) were used to evaluate the performance. Convolutional neural networks trained exclusively on downstream task data were employed for comparative analysis.

RESULTS

The pretrained foundation models demonstrated their ability to extract effective representations from multicontrast whole-brain volumes. The best classifiers, endowed with pretrained weights, showed remarkable performance with accuracies of 94.9, 92.3, and 80.4%, and corresponding AUC values of 0.981, 0.972, and 0.852 on independent test datasets in brain tumor detection, discrimination, and molecular status prediction, respectively. The classifiers with pretrained weights outperformed the convolutional classifiers trained from scratch by approximately 10% in terms of accuracy and AUC across all tasks. The saliency regions in the correctly predicted cases are mainly clustered around the tumors. Classifiers derived from the two dropout schemes differed significantly only in the detection of brain tumors.

CONCLUSIONS

Foundation models obtained from self-supervised learning have demonstrated encouraging potential for scalability and interpretability in downstream brain tumor-related tasks and hold promise for extension to neurological diseases with diffusely distributed lesions.

CLINICAL RELEVANCE STATEMENT

The application of our proposed method to the prediction of key molecular status in gliomas is expected to improve treatment planning and patient outcomes. Additionally, the foundation model we developed could serve as a cornerstone for advancing AI applications in the diagnosis of brain-related diseases.

Enhancing brain tumor detection: a novel CNN approach with advanced activation functions for accurate medical imaging analysis

Introduction

Brain tumors are characterized by abnormal cell growth within or around the brain, posing severe health risks often associated with high mortality rates. Various imaging techniques, including magnetic resonance imaging (MRI), are commonly employed to visualize the brain and identify malignant growths. Computer-aided diagnosis tools (CAD) utilizing Convolutional Neural Networks (CNNs) have proven effective in feature extraction and predictive analysis across diverse medical imaging modalities.

Methods

This study explores a CNN trained and evaluated with nine activation functions, encompassing eight established ones from the literature and a modified version of the soft sign activation function.

Results

The latter demonstrates notable efficacy in discriminating between four types of brain tumors in MR images, achieving an accuracy of 97.6%. The sensitivity for glioma is 93.7%; for meningioma, it is 97.4%; for cases with no tumor, it is 98.8%; and for pituitary tumors, it reaches 100%.

Discussion

In this manuscript, we propose an advanced CNN architecture that integrates a newly developed activation function. Our extensive experimentation and analysis showcase the model's remarkable ability to precisely distinguish between different types of brain tumors within a substantial and diverse dataset. The findings from our study suggest that this model could serve as an invaluable supplementary tool for healthcare practitioners, including specialized medical professionals and resident physicians, in the accurate diagnosis of brain tumors.

Precision meets generalization: Enhancing brain tumor classification via pretrained DenseNet with global average pooling and hyperparameter tuning

Brain tumors pose significant global health concerns due to their high mortality rates and limited treatment options. These tumors, arising from abnormal cell growth within the brain, exhibits various sizes and shapes, making their manual detection from magnetic resonance imaging (MRI) scans a subjective and challenging task for healthcare professionals, hence necessitating automated solutions. This study investigates the potential of deep learning, specifically the DenseNet architecture, to automate brain tumor classification, aiming to enhance accuracy and generalizability for clinical applications. We utilized the Figshare brain tumor dataset, comprising 3,064 T1-weighted contrast-enhanced MRI images from 233 patients with three prevalent tumor types: meningioma, glioma, and pituitary tumor. Four pre-trained deep learning models-ResNet, EfficientNet, MobileNet, and DenseNet-were evaluated using transfer learning from ImageNet. DenseNet achieved the highest test set accuracy of 96%, outperforming ResNet (91%), EfficientNet (91%), and MobileNet (93%). Therefore, we focused on improving the performance of the DenseNet, while considering it as base model. To enhance the generalizability of the base DenseNet model, we implemented a fine-tuning approach with regularization techniques, including data augmentation, dropout, batch normalization, and global average pooling, coupled with hyperparameter optimization. This enhanced DenseNet model achieved an accuracy of 97.1%. Our findings demonstrate the effectiveness of DenseNet with transfer learning and fine-tuning for brain tumor classification, highlighting its potential to improve diagnostic accuracy and reliability in clinical settings.

A Deep Learning Based Intelligent Decision Support System for Automatic Detection of Brain Tumor

Brain tumor (BT) is an awful disease and one of the foremost causes of death in human beings. BT develops mainly in 2 stages and varies by volume, form, and structure, and can be cured with special clinical procedures such as chemotherapy, radiotherapy, and surgical mediation. With revolutionary advancements in radiomics and research in medical imaging in the past few years, computer-aided diagnostic systems (CAD), especially deep learning, have played a key role in the automatic detection and diagnosing of various diseases and significantly provided accurate decision support systems for medical clinicians. Thus, convolution neural network (CNN) is a commonly utilized methodology developed for detecting various diseases from medical images because it is capable of extracting distinct features from an image under investigation. In this study, a deep learning approach is utilized to extricate distinct features from brain images in order to detect BT. Hence, CNN from scratch and transfer learning models (VGG-16, VGG-19, and LeNet-5) are developed and tested on brain images to build an intelligent decision support system for detecting BT. Since deep learning models require large volumes of data, data augmentation is used to populate the existing dataset synthetically in order to utilize the best fit detecting models. Hyperparameter tuning was conducted to set the optimum parameters for training the models. The achieved results show that VGG models outperformed others with an accuracy rate of 99.24%, average precision of 99%, average recall of 99%, average specificity of 99%, and average f1-score of 99% each. The results of the proposed models compared to the other state-of-the-art models in the literature show better performance of the proposed models in terms of accuracy, sensitivity, specificity, and f1-score. Moreover, comparative analysis shows that the proposed models are reliable in that they can be used for detecting BT as well as helping medical practitioners to diagnose BT.

Artificial Intelligence and Deep Learning in Revolutionizing Brain Tumor Diagnosis and Treatment: A Narrative Review

The emergence of artificial intelligence (AI) in the medical field holds promise in improving medical management, particularly in personalized strategies for the diagnosis and treatment of brain tumors. However, integrating AI into clinical practice has proven to be a challenge. Deep learning (DL) is very convenient for extracting relevant information from large amounts of data that has increased in medical history and imaging records, which shortens diagnosis time, that would otherwise overwhelm manual methods. In addition, DL aids in automated tumor segmentation, classification, and diagnosis. DL models such as the Brain Tumor Classification Model and the Inception-Resnet V2, or hybrid techniques that enhance these functions and combine DL networks with support vector machine and k-nearest neighbors, identify tumor phenotypes and brain metastases, allowing real-time decision-making and enhancing preoperative planning. AI algorithms and DL development facilitate radiological diagnostics such as computed tomography, positron emission tomography scans, and magnetic resonance imaging (MRI) by integrating two-dimensional and three-dimensional MRI using DenseNet and 3D convolutional neural network architectures, which enable precise tumor delineation. DL offers benefits in neuro-interventional procedures, and the shift toward computer-assisted interventions acknowledges the need for more accurate and efficient image analysis methods. Further research is needed to realize the potential impact of DL in improving these outcomes.

BrainCDNet: a concatenated deep neural network for the detection of brain tumors from MRI images

Introduction

Brain cancer is a frequently occurring disease around the globe and mostly developed due to the presence of tumors in/around the brain. Generally, the prevalence and incidence of brain cancer are much lower than that of other cancer types (breast, skin, lung, etc.). However, brain cancers are associated with high mortality rates, especially in adults, due to the false identification of tumor types, and delay in the diagnosis. Therefore, the minimization of false detection of brain tumor types and early diagnosis plays a crucial role in the improvement of patient survival rate. To achieve this, many researchers have recently developed deep learning (DL)-based approaches since they showed a remarkable performance, particularly in the classification task.

Methods

This article proposes a novel DL architecture named BrainCDNet. This model was made by concatenating the pooling layers and dealing with the overfitting issues by initializing the weights into layers using 'He Normal' initialization along with the batch norm and global average pooling (GAP). Initially, we sharpen the input images using a Nimble filter, which results in maintaining the edges and fine details. After that, we employed the suggested BrainCDNet for the extraction of relevant features and classification. In this work, two different forms of magnetic resonance imaging (MRI) databases such as binary (healthy vs. pathological) and multiclass (glioma vs. meningioma vs. pituitary) are utilized to perform all these experiments.

Results and discussion

Empirical evidence suggests that the presented model attained a significant accuracy on both datasets compared to the state-of-the-art approaches, with 99.45% (binary) and 96.78% (multiclass), respectively. Hence, the proposed model can be used as a decision-supportive tool for radiologists during the diagnosis of brain cancer patients.

Automatic detection of brain tumors with the aid of ensemble deep learning architectures and class activation map indicators by employing magnetic resonance images

Today, as in every life-threatening disease, early diagnosis of brain tumors plays a life-saving role. The brain tumor is formed by the transformation of brain cells from their normal structures into abnormal cell structures. These formed abnormal cells begin to form in masses in the brain regions. Nowadays, many different techniques are employed to detect these tumor masses, and the most common of these techniques is Magnetic Resonance Imaging (MRI). In this study, it is aimed to automatically detect brain tumors with the help of ensemble deep learning architectures (ResNet50, VGG19, InceptionV3 and MobileNet) and Class Activation Maps (CAMs) indicators by employing MRI images. The proposed system was implemented in three stages. In the first stage, it was determined whether there was a tumor in the MR images (Binary Approach). In the second stage, different tumor types (Normal, Glioma Tumor, Meningioma Tumor, Pituitary Tumor) were detected from MR images (Multi-class Approach). In the last stage, CAMs of each tumor group were created as an alternative tool to facilitate the work of specialists in tumor detection. The results showed that the overall accuracy of the binary approach was calculated as 100% on the ResNet50, InceptionV3 and MobileNet architectures, and 99.71% on the VGG19 architecture. Moreover, the accuracy values of 96.45% with ResNet50, 93.40% with VGG19, 85.03% with InceptionV3 and 89.34% with MobileNet architectures were obtained in the multi-class approach.

Automatic brain-tumor diagnosis using cascaded deep convolutional neural networks with symmetric U-Net and asymmetric residual-blocks

The use of various kinds of magnetic resonance imaging (MRI) techniques for examining brain tissue has increased significantly in recent years, and manual investigation of each of the resulting images can be a time-consuming task. This paper presents an automatic brain-tumor diagnosis system that uses a CNN for detection, classification, and segmentation of glioblastomas; the latter stage seeks to segment tumors inside glioma MRI images. The structure of the developed multi-unit system consists of two stages. The first stage is responsible for tumor detection and classification by categorizing brain MRI images into normal, high-grade glioma (glioblastoma), and low-grade glioma. The uniqueness of the proposed network lies in its use of different levels of features, including local and global paths. The second stage is responsible for tumor segmentation, and skip connections and residual units are used during this step. Using 1800 images extracted from the BraTS 2017 dataset, the detection and classification stage was found to achieve a maximum accuracy of 99%. The segmentation stage was then evaluated using the Dice score, specificity, and sensitivity. The results showed that the suggested deep-learning-based system ranks highest among a variety of different strategies reported in the literature.

Advancing glioma diagnosis: Integrating custom U-Net and VGG-16 for improved grading in MR imaging

In the realm of medical imaging, the precise segmentation and classification of gliomas represent fundamental challenges with profound clinical implications. Leveraging the BraTS 2018 dataset as a standard benchmark, this study delves into the potential of advanced deep learning models for addressing these challenges. We propose a novel approach that integrates a customized U-Net for segmentation and VGG-16 for classification. The U-Net, with its tailored encoder-decoder pathways, accurately identifies glioma regions, thus improving tumor localization. The fine-tuned VGG-16, featuring a customized output layer, precisely differentiates between low-grade and high-grade gliomas. To ensure consistency in data pre-processing, a standardized methodology involving gamma correction, data augmentation, and normalization is introduced. This novel integration surpasses existing methods, offering significantly improved glioma diagnosis, validated by high segmentation dice scores (WT: 0.96, TC: 0.92, ET: 0.89), and a remarkable overall classification accuracy of 97.89%. The experimental findings underscore the potential of integrating deep learning-based methodologies for tumor segmentation and classification in enhancing glioma diagnosis and formulating subsequent treatment strategies.

A Novel Ensemble Framework for Multi-Classification of Brain Tumors Using Magnetic Resonance Imaging

Brain tumors can have fatal consequences, affecting many body functions. For this reason, it is essential to detect brain tumor types accurately and at an early stage to start the appropriate treatment process. Although convolutional neural networks (CNNs) are widely used in disease detection from medical images, they face the problem of overfitting in the training phase on limited labeled and insufficiently diverse datasets. The existing studies use transfer learning and ensemble models to overcome these problems. When the existing studies are examined, it is evident that there is a lack of models and weight ratios that will be used with the ensemble technique. With the framework proposed in this study, several CNN models with different architectures are trained with transfer learning and fine-tuning on three brain tumor datasets. A particle swarm optimization-based algorithm determined the optimum weights for combining the five most successful CNN models with the ensemble technique. The results across three datasets are as follows: Dataset 1, 99.35% accuracy and 99.20 F1-score; Dataset 2, 98.77% accuracy and 98.92 F1-score; and Dataset 3, 99.92% accuracy and 99.92 F1-score. We achieved successful performances on three brain tumor datasets, showing that the proposed framework is reliable in classification. As a result, the proposed framework outperforms existing studies, offering clinicians enhanced decision-making support through its high-accuracy classification performance.

Advances in the Use of Deep Learning for the Analysis of Magnetic Resonance Image in Neuro-Oncology

Machine Learning is entering a phase of maturity, but its medical applications still lag behind in terms of practical use. The field of oncological radiology (and neuro-oncology in particular) is at the forefront of these developments, now boosted by the success of Deep-Learning methods for the analysis of medical images. This paper reviews in detail some of the most recent advances in the use of Deep Learning in this field, from the broader topic of the development of Machine-Learning-based analytical pipelines to specific instantiations of the use of Deep Learning in neuro-oncology; the latter including its use in the groundbreaking field of ultra-low field magnetic resonance imaging.

A Siamese-Transport Domain Adaptation Framework for 3D MRI Classification of Gliomas and Alzheimer's Diseases

Accurate and fully automated brain structure examination and prediction from 3D volumetric magnetic resonance imaging (MRI) is a necessary step in medical imaging analysis, which can assist greatly in clinical diagnosis. Traditional deep learning models suffer from severe performance degradation when applied to clinically acquired unlabeled data. The performance degradation is mainly caused by domain discrepancy such as different device types and parameter settings for data acquisition. However, existing approaches focus on the reduction of domain discrepancies but ignore the entanglement of semantic features and domain information. In this article, we explore the feature invariance of categories and domains in different projection spaces and propose a Siamese-Transport Domain Adaptation (STDA) method using a joint optimal transport theory and contrastive learning for automatic 3D MRI classification and glioma multi-grade prediction. Specifically, the learning framework updates the distribution of features across domains and categories by Siamese transport network training with an Optimal Cost Transfer Strategy (OCTS) and a Mutual Invariant Constraint (MIC) in two projective spaces to find multiple invariants in potential heterogeneity. We design three sets of transfer task scenarios with different source and target domains, and demonstrate that STDA yields substantially higher generalization performance than other state-of-the-art unsupervised domain adaptation (UDA) methods. The method is applicable on 3D MRI data from glioma to Alzheimer's disease and has promising applications in the future clinical diagnosis and treatment of brain diseases.

PFP-HOG: Pyramid and Fixed-Size Patch-Based HOG Technique for Automated Brain Abnormality Classification with MRI

Detecting neurological abnormalities such as brain tumors and Alzheimer's disease (AD) using magnetic resonance imaging (MRI) images is an important research topic in the literature. Numerous machine learning models have been used to detect brain abnormalities accurately. This study addresses the problem of detecting neurological abnormalities in MRI. The motivation behind this problem lies in the need for accurate and efficient methods to assist neurologists in the diagnosis of these disorders. In addition, many deep learning techniques have been applied to MRI to develop accurate brain abnormality detection models, but these networks have high time complexity. Hence, a novel hand-modeled feature-based learning network is presented to reduce the time complexity and obtain high classification performance. The model proposed in this work uses a new feature generation architecture named pyramid and fixed-size patch (PFP). The main aim of the proposed PFP structure is to attain high classification performance using essential feature extractors with both multilevel and local features. Furthermore, the PFP feature extractor generates low- and high-level features using a handcrafted extractor. To obtain the high discriminative feature extraction ability of the PFP, we have used histogram-oriented gradients (HOG); hence, it is named PFP-HOG. Furthermore, the iterative Chi2 (IChi2) is utilized to choose the clinically significant features. Finally, the k-nearest neighbors (kNN) with tenfold cross-validation is used for automated classification. Four MRI neurological databases (AD dataset, brain tumor dataset 1, brain tumor dataset 2, and merged dataset) have been utilized to develop our model. PFP-HOG and IChi2-based models attained 100%, 94.98%, 98.19%, and 97.80% using the AD dataset, brain tumor dataset1, brain tumor dataset 2, and merged brain MRI dataset, respectively. These findings not only provide an accurate and robust classification of various neurological disorders using MRI but also hold the potential to assist neurologists in validating manual MRI brain abnormality screening.

BTC-fCNN: Fast Convolution Neural Network for Multi-class Brain Tumor Classification

Timely prognosis of brain tumors has a crucial role for powerful healthcare of remedy-making plans. Manual classification of the brain tumors in magnetic resonance imaging (MRI) images is a challenging task, which relies on the experienced radiologists to identify and classify the brain tumor. Automated classification of different brain tumors is significant based on designing computer-aided diagnosis (CAD) systems. Existing classification methods suffer from unsatisfactory performance and/or large computational cost/ time. This paper proposed a fast and efficient classification process, called BTC-fCNN, which is a deep learning-based system to distinguish between different views of three brain tumor types, namely meningioma, glioma, and pituitary tumors. The proposed system's model was applied on MRI images from the Figshare dataset. It consists of 13 layers with few trainable parameters involving convolution layer, 1 × 1 convolution layer, average pooling, fully connected layer, and softmax layer. Five iterations including transfer learning and five-fold cross-validation for retraining are considered to increase the proposed model performance. The proposed model achieved 98.63% average accuracy, using five iterations with transfer learning, and 98.86% using retrained five-fold cross-validation (internal transfer learning between the folds). Various evaluation metrics were measured to evaluate the proposed model, such as precision, F-score, recall, specificity and confusion matrix. The proposed BTC-fCNN model outstrips the state-of-the-art and other well-known convolution neural networks (CNN).

Multimodal hybrid convolutional neural network based brain tumor grade classification

An abnormal growth or fatty mass of cells in the brain is called a tumor. They can be either healthy (normal) or become cancerous, depending on the structure of their cells. This can result in increased pressure within the cranium, potentially causing damage to the brain or even death. As a result, diagnostic procedures such as computed tomography, magnetic resonance imaging, and positron emission tomography, as well as blood and urine tests, are used to identify brain tumors. However, these methods can be labor-intensive and sometimes yield inaccurate results. Instead of these time-consuming methods, deep learning models are employed because they are less time-consuming, require less expensive equipment, produce more accurate results, and are easy to set up. In this study, we propose a method based on transfer learning, utilizing the pre-trained VGG-19 model. This approach has been enhanced by applying a customized convolutional neural network framework and combining it with pre-processing methods, including normalization and data augmentation. For training and testing, our proposed model used 80% and 20% of the images from the dataset, respectively. Our proposed method achieved remarkable success, with an accuracy rate of 99.43%, a sensitivity of 98.73%, and a specificity of 97.21%. The dataset, sourced from Kaggle for training purposes, consists of 407 images, including 257 depicting brain tumors and 150 without tumors. These models could be utilized to develop clinically useful solutions for identifying brain tumors in CT images based on these outcomes.

EFF_D_SVM: a robust multi-type brain tumor classification system

Brain tumors are one of the most threatening diseases to human health. Accurate identification of the type of brain tumor is essential for patients and doctors. An automated brain tumor diagnosis system based on Magnetic Resonance Imaging (MRI) can help doctors to identify the type of tumor and reduce their workload, so it is vital to improve the performance of such systems. Due to the challenge of collecting sufficient data on brain tumors, utilizing pre-trained Convolutional Neural Network (CNN) models for brain tumors classification is a feasible approach. The study proposes a novel brain tumor classification system, called EFF_D_SVM, which is developed on the basic of pre-trained EfficientNetB0 model. Firstly, a new feature extraction module EFF_D was proposed, in which the classification layer of EfficientNetB0 was replaced with two dropout layers and two dense layers. Secondly, the EFF_D model was fine-tuned using Softmax, and then features of brain tumor images were extracted using the fine-tuned EFF_D. Finally, the features were classified using Support Vector Machine (SVM). In order to verify the effectiveness of the proposed brain tumor classification system, a series of comparative experiments were carried out. Moreover, to understand the extracted features of the brain tumor images, Grad-CAM technology was used to visualize the proposed model. Furthermore, cross-validation was conducted to verify the robustness of the proposed model. The evaluation metrics including accuracy, F1-score, recall, and precision were used to evaluate proposed system performance. The experimental results indicate that the proposed model is superior to other state-of-the-art models.

Brain Tumor Detection Based on Deep Learning Approaches and Magnetic Resonance Imaging

The rapid development of abnormal brain cells that characterizes a brain tumor is a major health risk for adults since it can cause severe impairment of organ function and even death. These tumors come in a wide variety of sizes, textures, and locations. When trying to locate cancerous tumors, magnetic resonance imaging (MRI) is a crucial tool. However, detecting brain tumors manually is a difficult and time-consuming activity that might lead to inaccuracies. In order to solve this, we provide a refined You Only Look Once version 7 (YOLOv7) model for the accurate detection of meningioma, glioma, and pituitary gland tumors within an improved detection of brain tumors system. The visual representation of the MRI scans is enhanced by the use of image enhancement methods that apply different filters to the original pictures. To further improve the training of our proposed model, we apply data augmentation techniques to the openly accessible brain tumor dataset. The curated data include a wide variety of cases, such as 2548 images of gliomas, 2658 images of pituitary, 2582 images of meningioma, and 2500 images of non-tumors. We included the Convolutional Block Attention Module (CBAM) attention mechanism into YOLOv7 to further enhance its feature extraction capabilities, allowing for better emphasis on salient regions linked with brain malignancies. To further improve the model's sensitivity, we have added a Spatial Pyramid Pooling Fast+ (SPPF+) layer to the network's core infrastructure. YOLOv7 now includes decoupled heads, which allow it to efficiently glean useful insights from a wide variety of data. In addition, a Bi-directional Feature Pyramid Network (BiFPN) is used to speed up multi-scale feature fusion and to better collect features associated with tumors. The outcomes verify the efficiency of our suggested method, which achieves a higher overall accuracy in tumor detection than previous state-of-the-art models. As a result, this framework has a lot of potential as a helpful decision-making tool for experts in the field of diagnosing brain tumors.

AI-Based Glioma Grading for a Trustworthy Diagnosis: An Analytical Pipeline for Improved Reliability

Glioma is the most common type of tumor in humans originating in the brain. According to the World Health Organization, gliomas can be graded on a four-stage scale, ranging from the most benign to the most malignant. The grading of these tumors from image information is a far from trivial task for radiologists and one in which they could be assisted by machine-learning-based decision support. However, the machine learning analytical pipeline is also fraught with perils stemming from different sources, such as inadvertent data leakage, adequacy of 2D image sampling, or classifier assessment biases. In this paper, we analyze a glioma database sourced from multiple datasets using a simple classifier, aiming to obtain a reliable tumor grading and, on the way, we provide a few guidelines to ensure such reliability. Our results reveal that by focusing on the tumor region of interest and using data augmentation techniques we significantly enhanced the accuracy and confidence in tumor classifications. Evaluation on an independent test set resulted in an AUC-ROC of 0.932 in the discrimination of low-grade gliomas from high-grade gliomas, and an AUC-ROC of 0.893 in the classification of grades 2, 3, and 4. The study also highlights the importance of providing, beyond generic classification performance, measures of how reliable and trustworthy the model's output is, thus assessing the model's certainty and robustness.

A novel Gateaux derivatives with efficient DCNN-Resunet method for segmenting multi-class brain tumor

In hospitals and pathology, observing the features and locations of brain tumors in Magnetic Resonance Images (MRI) is a crucial task for assisting medical professionals in both treatment and diagnosis. The multi-class information about the brain tumor is often obtained from the patient's MRI dataset. However, this information may vary in different shapes and sizes for various brain tumors, making it difficult to detect their locations in the brain. To resolve these issues, a novel customized Deep Convolution Neural Network (DCNN) based Residual-Unet (ResUnet) model with Transfer Learning (TL) is proposed for predicting the locations of the brain tumor in an MRI dataset. The DCNN model has been used to extract the features from input images and select the Region Of Interest (ROI) by using the TL technique for training it faster. Furthermore, the min-max normalizing approach is used to enhance the color intensity value for particular ROI boundary edges in the brain tumor images. Specifically, the boundary edges of the brain tumors have been detected by utilizing Gateaux Derivatives (GD) method to identify the multi-class brain tumors precisely. The proposed scheme has been validated on two datasets namely the brain tumor, and Figshare MRI datasets for detecting multi-class Brain Tumor Segmentation (BTS).The experimental results have been analyzed by evaluation metrics namely, accuracy (99.78, and 99.03), Jaccard Coefficient (93.04, and 94.95), Dice Factor Coefficient (DFC) (92.37, and 91.94), Mean Absolute Error (MAE) (0.0019, and 0.0013), and Mean Squared Error (MSE) (0.0085, and 0.0012) for proper validation. The proposed system outperforms the state-of-the-art segmentation models on the MRI brain tumor dataset.

Performance of deep learning algorithms to distinguish high-grade glioma from low-grade glioma: A systematic review and meta-analysis

This study aims to evaluate deep learning (DL) performance in differentiating low- and high-grade glioma. Search online database for studies continuously published from 1st January 2015 until 16th August 2022. The random-effects model was used for synthesis, based on pooled sensitivity (SE), specificity (SP), and area under the curve (AUC). Heterogeneity was estimated using the Higgins inconsistency index (I²). 33 were ultimately included in the meta-analysis. The overall pooled SE and SP were 94% and 93%, with an AUC of 0.98. There was great heterogeneity in this field. Our evidence-based study shows DL achieves high accuracy in glioma grading. Subgroup analysis reveals several limitations in this field: 1) Diagnostic trials require standard method for data merging for AI; 2) small sample size; 3) poor-quality image preprocessing; 4) not standard algorithm development; 5) not standard data report; 6) different definition of HGG and LGG; and 7) poor extrapolation.

BMRI-NET: A Deep Stacked Ensemble Model for Multi-class Brain Tumor Classification from MRI Images

Brain tumors are one of the most dangerous health problems for adults and children in many countries. Any failure in the diagnosis of brain tumors may lead to shortening of human life. Accurate and timely diagnosis of brain tumors provides appropriate treatment to increase the patient's chances of survival. Due to the different characteristics of tumors, one of the challenging problems is the classification of three types of brain tumors. With the advent of deep learning (DL) models, three classes of brain tumor classification have been addressed. However, the accuracy of these methods requires significant improvements in brain image classification. The main goal of this article is to design a new method for classifying the three types of brain tumors with extremely high accuracy. In this paper, we propose a novel deep stacked ensemble model called "BMRI-NET" that can detect brain tumors from MR images with high accuracy and recall. The stacked ensemble proposed in this article adapts three pre-trained models, namely DenseNe201, ResNet152V2, and InceptionResNetV2, to improve the generalization capability. We combine decisions from the three models using the stacking technique to obtain final results that are much more accurate than individual models for detecting brain tumors. The efficacy of the proposed model is evaluated on the Figshare brain MRI dataset of three types of brain tumors consisting of 3064 images. The experimental results clearly highlight the robustness of the proposed BMRI-NET model by achieving an overall classification of 98.69% and an average recall, F1-score and MCC of 98.33%, 98.40, and 97.95%, respectively. The results indicate that the proposed BMRI-NET model is superior to existing methods and can assist healthcare professionals in the diagnosis of brain tumors.

A Novel Approach for Brain Tumor Classification Using an Ensemble of Deep and Hand-Crafted Features

One of the most severe types of cancer caused by the uncontrollable proliferation of brain cells inside the skull is brain tumors. Hence, a fast and accurate tumor detection method is critical for the patient's health. Many automated artificial intelligence (AI) methods have recently been developed to diagnose tumors. These approaches, however, result in poor performance; hence, there is a need for an efficient technique to perform precise diagnoses. This paper suggests a novel approach for brain tumor detection via an ensemble of deep and hand-crafted feature vectors (FV). The novel FV is an ensemble of hand-crafted features based on the GLCM (gray level co-occurrence matrix) and in-depth features based on VGG16. The novel FV contains robust features compared to independent vectors, which improve the suggested method's discriminating capabilities. The proposed FV is then classified using SVM or support vector machines and the k-nearest neighbor classifier (KNN). The framework achieved the highest accuracy of 99% on the ensemble FV. The results indicate the reliability and efficacy of the proposed methodology; hence, radiologists can use it to detect brain tumors through MRI (magnetic resonance imaging). The results show the robustness of the proposed method and can be deployed in the real environment to detect brain tumors from MRI images accurately. In addition, the performance of our model was validated via cross-tabulated data.

Segmentation and classification of brain tumors using fuzzy 3D highlighting and machine learning

PURPOSE

Brain tumors are among the most lethal forms of cancer, so early diagnosis is crucial. As a result of machine learning algorithms, radiologists can now make accurate diagnoses of tumors without resorting to invasive procedures. There are, however, a number of obstacles to overcome. To begin, classifying brain tumors presents a significant difficulty in developing the most effective deep learning framework. Furthermore, physically dividing the brain tumor is a time-consuming and challenging process that requires the expertise of medical professionals.

METHODS

Here, we have discussed the use of a fuzzy 3D highlighting method for the segmentation of brain tumors and the selection of suspect tumor areas based on the geometric characteristics of MRI scans. After features were extracted from the brain tumor section, the images were classified using two machine learning methods: a support vector machine technique optimized with the grasshopper optimization algorithm (GOA-SVM), and a deep neural network technique based on features selected with the genetic algorithm (GA-DNN). This classifies brain tumors into benign and malignant. Implemented on the MATLAB platform, the proposed method is evaluated for effectiveness using performance metrics like sensitivity, accuracy, specificity, and Youden index.

RESULTS

From these results, it is clear that the proposed strategy is significantly superior to the alternatives. The average classification accuracy was determined to be 97.53%, 97.65%, for GA-DNN and GOA-SVM, respectively.

CONCLUSION

These findings may be a quick and important step to detect the presence of lesions at the same time as cancerous tumors in neurology diagnosis.

Optimized deep learning architecture for brain tumor classification using improved Hunger Games Search Algorithm

One of the worst diseases is a brain tumor, which is defined by abnormal development of synapses in the brain. Early detection of brain tumors is essential for improving prognosis, and classifying tumors is a vital step in the disease's treatment. Different classification strategies using deep learning have been presented for the diagnosis of brain tumors. However, several challenges exist, such as the need for a competent specialist in classifying brain cancers by deep learning models and the problem of building the most precise deep learning model for categorizing brain tumors. We propose an evolved and highly efficient model based on deep learning and improved metaheuristic algorithms to address these challenges. Specifically, we develop an optimized residual learning architecture for classifying multiple brain tumors and propose an improved variant of the Hunger Games Search algorithm (I-HGS) based on combining two enhancing strategies: Local Escaping Operator (LEO) and Brownian motion. These two strategies balance solution diversity and convergence speed, boosting the optimization performance and staying away from the local optima. First, we have evaluated the I-HGS algorithm on the IEEE Congress on Evolutionary Computation held in 2020 (CEC'2020) test functions, demonstrating that I-HGS outperformed the basic HGS and other popular algorithms regarding statistical convergence, and various measures. The suggested model is then applied to the optimization of the hyperparameters of the Residual Network 50 (ResNet50) model (I-HGS-ResNet50) for brain cancer identification, proving its overall efficacy. We utilize several publicly available, gold-standard datasets of brain MRI images. The proposed I-HGS-ResNet50 model is compared with other existing studies as well as with other deep learning architectures, including Visual Geometry Group 16-layer (VGG16), MobileNet, and Densely Connected Convolutional Network 201 (DenseNet201). The experiments demonstrated that the proposed I-HGS-ResNet50 model surpasses the previous studies and other well-known deep learning models. I-HGS-ResNet50 acquired an accuracy of 99.89%, 99.72%, and 99.88% for the three datasets. These results efficiently prove the potential of the proposed I-HGS-ResNet50 model for accurate brain tumor classification.

Interpretable features fusion with precision MRI images deep hashing for brain tumor detection

BACKGROUND AND OBJECTIVE

Brain tumor is a deadly disease that can affect people of all ages. Radiologists play a critical role in the early diagnosis and treatment of the 14,000 persons diagnosed with brain tumors on average each year. The best method for tumor detection with computer-aided diagnosis systems (CADs) is Magnetic Resonance Imaging (MRI). However, manual evaluation using conventional approaches may result in a number of inaccuracies due to the complicated tissue properties of a large number of images. Therefore a precision medical image hashing approach is proposed that combines interpretability and feature fusion using MRI images of brain tumors, to address the issue of medical image retrieval.

METHODS

A precision hashing method combining interpretability and feature fusion is proposed to recover the problem of low image resolutions in brain tumor detection on the Brain-Tumor-MRI (BT-MRI) dataset. First, the dataset is pre-trained with the DenseNet201 network using the Comparison-to-Learn method. Then, a global network is created that generates the salience map to yield a mask crop with local region discrimination. Finally, the local network features inputs and public features expressing the local discriminant regions are concatenated for the pooling layer. A hash layer is added between the fully connected layer and the classification layer of the backbone network to generate high-quality hash codes. The final result is obtained by calculating the hash codes with the similarity metric.

RESULTS

Experimental results with the BT-MRI dataset showed that the proposed method can effectively identify tumor regions and more accurate hash codes can be generated by using the three loss functions in feature fusion. It has been demonstrated that the accuracy of medical image retrieval is effectively increased when our method is compared with existing image retrieval approaches.

CONCLUSIONS

Our method has demonstrated that the accuracy of medical image retrieval can be effectively increased and potentially applied to CADs.

Automated Classification of Brain Tumors from Magnetic Resonance Imaging Using Deep Learning

Brain tumor classification is crucial for medical evaluation in computer-assisted diagnostics (CAD). However, manual diagnosis of brain tumors from magnetic resonance imaging (MRI) can be time-consuming and complex, leading to inaccurate detection and classification. This is mainly because brain tumor identification is a complex procedure that relies on different modules. The advancements in Deep Learning (DL) have assisted in the automated process of medical images and diagnostics for various medical conditions, which benefits the health sector. Convolutional Neural Network (CNN) is one of the most prominent DL methods for visual learning and image classification tasks. This study presents a novel CNN algorithm to classify the brain tumor types of glioma, meningioma, and pituitary. The algorithm was tested on benchmarked data and compared with the existing pre-trained VGG16, VGG19, ResNet50, MobileNetV2, and InceptionV3 algorithms reported in the literature. The experimental results have indicated a high classification accuracy of 98.04%, precision, recall, and f1-score success rate of 98%, respectively. The classification results proved that the most common kinds of brain tumors could be categorized with a high level of accuracy. The presented algorithm has good generalization capability and execution speed that can be helpful in the field of medicine to assist doctors in making prompt and accurate decisions associated with brain tumor diagnosis.

Machine Learning Analysis of RNA-seq Data for Diagnostic and Prognostic Prediction of Colon Cancer

Data from omics studies have been used for prediction and classification of various diseases in biomedical and bioinformatics research. In recent years, Machine Learning (ML) algorithms have been used in many different fields related to healthcare systems, especially for disease prediction and classification tasks. Integration of molecular omics data with ML algorithms has offered a great opportunity to evaluate clinical data. RNA sequence (RNA-seq) analysis has been emerged as the gold standard for transcriptomics analysis. Currently, it is being used widely in clinical research. In our present work, RNA-seq data of extracellular vesicles (EV) from healthy and colon cancer patients are analyzed. Our aim is to develop models for prediction and classification of colon cancer stages. Five different canonical ML and Deep Learning (DL) classifiers are used to predict colon cancer of an individual with processed RNA-seq data. The classes of data are formed on the basis of both colon cancer stages and cancer presence (healthy or cancer). The canonical ML classifiers, which are k-Nearest Neighbor (kNN), Logistic Model Tree (LMT), Random Tree (RT), Random Committee (RC), and Random Forest (RF), are tested with both forms of the data. In addition, to compare the performance with canonical ML models, One-Dimensional Convolutional Neural Network (1-D CNN), Long Short-Term Memory (LSTM), and Bidirectional LSTM (BiLSTM) DL models are utilized. Hyper-parameter optimizations of DL models are constructed by using genetic meta-heuristic optimization algorithm (GA). The best accuracy in cancer prediction is obtained with RC, LMT, and RF canonical ML algorithms as 97.33%. However, RT and kNN show 95.33% performance. The best accuracy in cancer stage classification is achieved with RF as 97.33%. This result is followed by LMT, RC, kNN, and RT with 96.33%, 96%, 94.66%, and 94%, respectively. According to the results of the experiments with DL algorithms, the best accuracy in cancer prediction is obtained with 1-D CNN as 97.67%. BiLSTM and LSTM show 94.33% and 93.67% performance, respectively. In classification of the cancer stages, the best accuracy is achieved with BiLSTM as 98%. 1-D CNN and LSTM show 97% and 94.33% performance, respectively. The results reveal that both canonical ML and DL models may outperform each other for different numbers of features.

A review of deep learning-based multiple-lesion recognition from medical images: classification, detection and segmentation

Deep learning-based methods have become the dominant methodology in medical image processing with the advancement of deep learning in natural image classification, detection, and segmentation. Deep learning-based approaches have proven to be quite effective in single lesion recognition and segmentation. Multiple-lesion recognition is more difficult than single-lesion recognition due to the little variation between lesions or the too wide range of lesions involved. Several studies have recently explored deep learning-based algorithms to solve the multiple-lesion recognition challenge. This paper includes an in-depth overview and analysis of deep learning-based methods for multiple-lesion recognition developed in recent years, including multiple-lesion recognition in diverse body areas and recognition of whole-body multiple diseases. We discuss the challenges that still persist in the multiple-lesion recognition tasks by critically assessing these efforts. Finally, we outline existing problems and potential future research areas, with the hope that this review will help researchers in developing future approaches that will drive additional advances.

Investigating the Impact of Two Major Programming Environments on the Accuracy of Deep Learning-Based Glioma Detection from MRI Images

Brain tumors have been the subject of research for many years. Brain tumors are typically classified into two main groups: benign and malignant tumors. The most common tumor type among malignant brain tumors is known as glioma. In the diagnosis of glioma, different imaging technologies could be used. Among these techniques, MRI is the most preferred imaging technology due to its high-resolution image data. However, the detection of gliomas from a huge set of MRI data could be challenging for the practitioners. In order to solve this concern, many Deep Learning (DL) models based on Convolutional Neural Networks (CNNs) have been proposed to be used in detecting glioma. However, understanding which CNN architecture would work efficiently under various conditions including development environment or programming aspects as well as performance analysis has not been studied so far. In this research work, therefore, the purpose is to investigate the impact of two major programming environments (namely, MATLAB and Python) on the accuracy of CNN-based glioma detection from Magnetic Resonance Imaging (MRI) images. To this end, experiments on the Brain Tumor Segmentation (BraTS) dataset (2016 and 2017) consisting of multiparametric magnetic MRI images are performed by implementing two popular CNN architectures, the three-dimensional (3D) U-Net and the V-Net in the programming environments. From the results, it is concluded that the use of Python with Google Colaboratory (Colab) might be highly useful in the implementation of CNN-based models for glioma detection. Moreover, the 3D U-Net model is found to perform better, attaining a high accuracy on the dataset. The authors believe that the results achieved from this study would provide useful information to the research community in their appropriate implementation of DL approaches for brain tumor detection.

A Bibliometric Review: Brain Tumor Magnetic Resonance Imagings Using Different Convolutional Neural Network Architectures

BACKGROUND

Numerous scientists and researchers have been developing advanced procedures and methods for diagnosing the kind and phase of a human tumor. Brain tumors, which are neoplastic and abnormal developments of brain cells, are one of the most prominent causes of death. Brain tumors, also known as lesions or neoplasia, may be roughly classified as either primary or metastatic. Primary brain tumors arise from brain tissue and its surrounding environment. The recognition of brain tumors using magnetic resonance images via a deep learning technique such as convolutional neural network (CNN) has garnered significant academic interest over the last few decades.

METHODS

In this study, a detailed evaluation based on bibliometrics is considered in order to synthesize and organize the available academic literature and to identify current research trends and hotspots. We used bibliometric methodologies and a literature review for the CNN-based brain tumor to synthesize and evaluate prior studies.

RESULTS

For this bibliometric analysis, we applied the Visualization of Similarity Viewer program to classify the major publications, notable journals, financial sponsors, and affiliations.

CONCLUSIONS

In conclusion, we suggest that one of the next paths of study will be the incorporation of other databases to advance CNN-based brain tumor identification from magnetic resonance images. No drug dosages are applied in this work.

Role of Ensemble Deep Learning for Brain Tumor Classification in Multiple Magnetic Resonance Imaging Sequence Data

The biopsy is a gold standard method for tumor grading. However, due to its invasive nature, it has sometimes proved fatal for brain tumor patients. As a result, a non-invasive computer-aided diagnosis (CAD) tool is required. Recently, many magnetic resonance imaging (MRI)-based CAD tools have been proposed for brain tumor grading. The MRI has several sequences, which can express tumor structure in different ways. However, a suitable MRI sequence for brain tumor classification is not yet known. The most common brain tumor is 'glioma', which is the most fatal form. Therefore, in the proposed study, to maximize the classification ability between low-grade versus high-grade glioma, three datasets were designed comprising three MRI sequences: T1-Weighted (T1W), T2-weighted (T2W), and fluid-attenuated inversion recovery (FLAIR). Further, five well-established convolutional neural networks, AlexNet, VGG16, ResNet18, GoogleNet, and ResNet50 were adopted for tumor classification. An ensemble algorithm was proposed using the majority vote of above five deep learning (DL) models to produce more consistent and improved results than any individual model. Five-fold cross validation (K5-CV) protocol was adopted for training and testing. For the proposed ensembled classifier with K5-CV, the highest test accuracies of 98.88 ± 0.63%, 97.98 ± 0.86%, and 94.75 ± 0.61% were achieved for FLAIR, T2W, and T1W-MRI data, respectively. FLAIR-MRI data was found to be most significant for brain tumor classification, where it showed a 4.17% and 0.91% improvement in accuracy against the T1W-MRI and T2W-MRI sequence data, respectively. The proposed ensembled algorithm (MajVot) showed significant improvements in the average accuracy of three datasets of 3.60%, 2.84%, 1.64%, 4.27%, and 1.14%, respectively, against AlexNet, VGG16, ResNet18, GoogleNet, and ResNet50.

Brain Tumour Region Extraction Using Novel Self-Organising Map-Based KFCM Algorithm

Medical professionals need help finding tumours in the ground truth image of the brain because the tumours’ location, contrast, intensity, size, and shape vary between images because of different acquisition methods, modalities, and the patient’s age. The medical examiner has difficulty manually separating a tumour from other parts of a Magnetic Resonance Imaging (MRI) image. Many semi- and fully automated brain tumour detection systems have been written about in the literature, and they keep improving. The segmentation literature has seen several transformations throughout the years. An in-depth examination of these methods will be the focus of this investigation. We look at the most recent soft computing technologies used in MRI brain analysis through several review papers. This study looks at Self-Organising maps (SOM) with K-means and the kernel Fuzzy c-means (KFCM) method for segmenting them. The suggested SOM networks were first compared to K-means analysis in an experiment based on datasets with well-known cluster solutions. Later, the SOM is combined with KFCM, reducing time complexity and producing more accurate results than other methods. Experiments show that skewed data improves networks’ performance with more SOMs. Finally, performance measures in real-time datasets are analysed using machine learning approaches. The results show that the proposed algorithm has good sensitivity and better accuracy than k-means and other state-of-art methods.

Imaging of Insect Hole in Living Tree Trunk Based on Joint Driven Algorithm of Electromagnetic Inverse Scattering

Trunk pests have always been one of the most important species of tree pests. Trees eroded by trunk pests will be blocked in the transport of nutrients and water and will wither and die or be broken by strong winds. Most pests are social and distributed in the form of communities inside trees. However, it is difficult to know from the outside if a tree is infected inside. A new method for the non-invasive detecting of tree interiors is proposed to identify trees eroded by trunk pests. The method is based on electromagnetic inverse scattering. The scattered field data are obtained by an electromagnetic wave receiver. A Joint-Driven algorithm is proposed to realize the electromagnetic scattered data imaging to determine the extent and location of pest erosion of the trunk. This imaging method can effectively solve the problem of unclear imaging in the xylem of living trees due to the small area of the pest community. The Joint-Driven algorithm proposed by our group can achieve accurate imaging with a ratio of pest community radius to live tree radius equal to 1:60 under the condition of noise doping. The Joint-Driven algorithm proposed in this paper reduces the time cost and computational complexity of tree internal defect detection and improves the clarity and accuracy of tree internal defect inversion images.

Efficient framework for brain tumor detection using different deep learning techniques

The brain tumor is an urgent malignancy caused by unregulated cell division. Tumors are classified using a biopsy, which is normally performed after the final brain surgery. Deep learning technology advancements have assisted the health professionals in medical imaging for the medical diagnosis of several symptoms. In this paper, transfer-learning-based models in addition to a Convolutional Neural Network (CNN) called BRAIN-TUMOR-net trained from scratch are introduced to classify brain magnetic resonance images into tumor or normal cases. A comparison between the pre-trained InceptionResNetv2, Inceptionv3, and ResNet50 models and the proposed BRAIN-TUMOR-net is introduced. The performance of the proposed model is tested on three publicly available Magnetic Resonance Imaging (MRI) datasets. The simulation results show that the BRAIN-TUMOR-net achieves the highest accuracy compared to other models. It achieves 100%, 97%, and 84.78% accuracy levels for three different MRI datasets. In addition, the k-fold cross-validation technique is used to allow robust classification. Moreover, three different unsupervised clustering techniques are utilized for segmentation.

Two stages cascades neural network for multi-class brain lesion classification system in MRI images

Brain tumor is one of the deadliest cancerous diseases and their severity has turned them into the leading cause of cancer-related mortality. Automatic detection and classification of severity-level for a brain tumor using MRI is a complex process in multilevel classification and needs an improved learning method without computational complexity. In this research article, we propose an innovative Multi-Dimensional Cascades Neural Network work (MDCNet) that takes full advantage of two networks with different dimensions, which can balance the complete semantic information and high-resolution detail information of a large-volume MRI image. In stage 1, a shallow-layer-enhanced 3D location net obtains the location and rough segmentation of brain lesions. In stage 2, a high-resolution attention map is used to obtain the 2D high-resolution image slice sets from the original image and the output of stage 1. The high-resolution images pick up the lost detailed information, refining the boundaries further. Moreover, a multi-view 2.5D net composed of three 2D refinement sub-networks is applied to deeply explore the morphological characteristics of all brain lesions from different perspectives, which compensates for the mistakes and missing spatial information of a single view, increasing the stability of the whole algorithm. The robustness of the proposed model is analyzed using several performance metrics of three different data sets. Through the prominent performance, the proposed model can outperform other existing models attaining an average accuracy of 99.13%. Here, the individual accuracy for Dataset 1, Dataset 2, and Dataset 3 is 99.67%, 98.16%, and 99.76% respectively.

Clinical Decision Support Framework for Segmentation and Classification of Brain Tumor MRIs Using a U-Net and DCNN Cascaded Learning Algorithm

Brain tumors (BTs) are an uncommon but fatal kind of cancer. Therefore, the development of computer-aided diagnosis (CAD) systems for classifying brain tumors in magnetic resonance imaging (MRI) has been the subject of many research papers so far. However, research in this sector is still in its early stage. The ultimate goal of this research is to develop a lightweight effective implementation of the U-Net deep network for use in performing exact real-time segmentation. Moreover, a simplified deep convolutional neural network (DCNN) architecture for the BT classification is presented for automatic feature extraction and classification of the segmented regions of interest (ROIs). Five convolutional layers, rectified linear unit, normalization, and max-pooling layers make up the DCNN's proposed simplified architecture. The introduced method was verified on multimodal brain tumor segmentation (BRATS 2015) datasets. Our experimental results on BRATS 2015 acquired Dice similarity coefficient (DSC) scores, sensitivity, and classification accuracy of 88.8%, 89.4%, and 88.6% for high-grade gliomas. When it comes to segmenting BRATS 2015 BT images, the performance of our proposed CAD framework is on par with existing state-of-the-art methods. However, the accuracy achieved in this study for the classification of BT images has improved upon the accuracy reported in prior studies. Image classification accuracy for BRATS 2015 BT has been improved from 88% to 88.6%.

ColoRectalCADx: Expeditious Recognition of Colorectal Cancer with Integrated Convolutional Neural Networks and Visual Explanations Using Mixed Dataset Evidence

Colorectal cancer typically affects the gastrointestinal tract within the human body. Colonoscopy is one of the most accurate methods of detecting cancer. The current system facilitates the identification of cancer by computer-assisted diagnosis (CADx) systems with a limited number of deep learning methods. It does not imply the depiction of mixed datasets for the functioning of the system. The proposed system, called ColoRectalCADx, is supported by deep learning (DL) models suitable for cancer research. The CADx system comprises five stages: convolutional neural networks (CNN), support vector machine (SVM), long short-term memory (LSTM), visual explanation such as gradient-weighted class activation mapping (Grad-CAM), and semantic segmentation phases. Here, the key components of the CADx system are equipped with 9 individual and 12 integrated CNNs, implying that the system consists mainly of investigational experiments with a total of 21 CNNs. In the subsequent phase, the CADx has a combination of CNNs of concatenated transfer learning functions associated with the machine SVM classification. Additional classification is applied to ensure effective transfer of results from CNN to LSTM. The system is mainly made up of a combination of CVC Clinic DB, Kvasir2, and Hyper Kvasir input as a mixed dataset. After CNN and LSTM, in advanced stage, malignancies are detected by using a better polyp recognition technique with Grad-CAM and semantic segmentation using U-Net. CADx results have been stored on Google Cloud for record retention. In these experiments, among all the CNNs, the individual CNN DenseNet-201 (87.1% training and 84.7% testing accuracies) and the integrated CNN ADaDR-22 (84.61% training and 82.17% testing accuracies) were the most efficient for cancer detection with the CNN+LSTM model. ColoRectalCADx accurately identifies cancer through individual CNN DesnseNet-201 and integrated CNN ADaDR-22. In Grad-CAM's visual explanations, CNN DenseNet-201 displays precise visualization of polyps, and CNN U-Net provides precise malignant polyps.

The prediction of cardiac abnormality and enhancement in minority class accuracy from imbalanced ECG signals using modified deep neural network models

Cardiovascular disease (CVD) is the most fatal disease in the world, so its accurate and automated detection in the early stages will certainly support the medical expert in timely diagnosis and treatment, which can save many lives. Many types of research have been carried out in this regard, but due to the problem of data imbalance in the medical and health care sector, it may not provide the desired results in all aspects. To overcome this problem, a sequential ensemble technique has been proposed that detects 6 types of cardiac arrhythmias on large ECG imbalanced datasets, and the data imbalanced issue of the ECG dataset has been addressed by using a hybrid data resampling technique called "Synthetically Minority Oversampling Technique and Tomek Link (SMOTE + Tomek)". The sequential ensemble technique employs two distinct deep learning models: Convolutional Neural Network (CNN) and a hybrid model, CNN with Long Short-Term Memory Network (CNN-LSTM). The two standard datasets "MIT-BIH arrhythmias database" (MITDB) and "PTB diagnostic database" (PTBDB) are combined and extracted 23, 998 ECG beats for the model validation. In this work, the three models CNN, CNN-LSTM, and ensemble approach were tested on four kinds of ECG datasets: the original data (imbalanced), the data sampled using a random oversampled technique, data sampled using SMOTE, and the dataset resampled using SMOTE + Tomek algorithm. The overall highest accuracy was obtained of 99.02% on the SMOTE + Tomek sampled dataset by ensemble technique and the minority class accuracy result (Recall) is improved by 20% as compared to the imbalanced data.

Detection of meningioma tumor images using Modified Empirical Mode Decomposition (MEMD) and convolutional neural networks

The meningioma brain tumor detection is more important than the other tumor detection such as Glioma and Glioblastoma, due to its high severity level. The tumor pixel density of meningioma tumor is high and it leads to sudden death if it is not detected timely. The meningioma images are detected using Modified Empirical Mode Decomposition- Convolutional Neural Networks (MEMD-CNN) classification approach. This method has the following stages data augmentation, spatial-frequency transformation, feature computations, classifications and segmentation. The brain image samples are increased using data augmentation process for improving the meningioma detection rate. The data augmented images are spatially transformed into frequency format using MEMD transformation method. Then, the external empirical mode features are computed from this transformed image and they are fed into CNN architecture to classify the source brain image into either meningioma or non-meningioma. The pixels belonging tumor category are segmented using morphological opening-closing functions. The meningioma detection system obtains 99.4% of Meningioma Classification Rate (MCR) and 99.3% of Non-Meningioma Classification Rate (NMCR) on the meningioma and non-meningioma images. This MEMD-CNN technique for meningioma identification attains 98.93% of SET, 99.13% of SPT, 99.18% of MSA, 99.14% of PR and 99.13% of FS. From the statistical comparative analysis of the proposed MEMD-CNN system with other conventional detection systems, the proposed method provides optimum tumor segmentation results.